Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells.

Loré K, Smed-Sörensen A, Vasudevan J, Mascola JR, Koup RA.

J Exp Med. 2005 Jun 20;201(12):2023-33.

2.

Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.

Loré K, Betts MR, Brenchley JM, Kuruppu J, Khojasteh S, Perfetto S, Roederer M, Seder RA, Koup RA.

J Immunol. 2003 Oct 15;171(8):4320-8.

3.

Opposing roles of blood myeloid and plasmacytoid dendritic cells in HIV-1 infection of T cells: transmission facilitation versus replication inhibition.

Groot F, van Capel TM, Kapsenberg ML, Berkhout B, de Jong EC.

Blood. 2006 Sep 15;108(6):1957-64. Epub 2006 May 16.

4.

Selective transmission of R5 HIV-1 over X4 HIV-1 at the dendritic cell-T cell infectious synapse is determined by the T cell activation state.

Yamamoto T, Tsunetsugu-Yokota Y, Mitsuki YY, Mizukoshi F, Tsuchiya T, Terahara K, Inagaki Y, Yamamoto N, Kobayashi K, Inoue J.

PLoS Pathog. 2009 Jan;5(1):e1000279. doi: 10.1371/journal.ppat.1000279. Epub 2009 Jan 30.

5.

Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection.

Duvall MG, Loré K, Blaak H, Ambrozak DA, Adams WC, Santos K, Geldmacher C, Mascola JR, McMichael AJ, Jaye A, Whittle HC, Rowland-Jones SL, Koup RA.

J Virol. 2007 Dec;81(24):13486-98. Epub 2007 Oct 3.

6.

Dendritic cells preferentially transfer CXCR4-using human immunodeficiency virus type 1 variants to CD4+ T lymphocytes in trans.

van Montfort T, Thomas AA, Pollakis G, Paxton WA.

J Virol. 2008 Aug;82(16):7886-96. doi: 10.1128/JVI.00245-08. Epub 2008 Jun 4.

7.

Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.

Tel J, Schreibelt G, Sittig SP, Mathan TS, Buschow SI, Cruz LJ, Lambeck AJ, Figdor CG, de Vries IJ.

Blood. 2013 Jan 17;121(3):459-67. doi: 10.1182/blood-2012-06-435644. Epub 2012 Dec 4.

8.

Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity.

Fonteneau JF, Gilliet M, Larsson M, Dasilva I, Münz C, Liu YJ, Bhardwaj N.

Blood. 2003 May 1;101(9):3520-6. Epub 2003 Jan 2.

9.
10.

Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load.

Donaghy H, Pozniak A, Gazzard B, Qazi N, Gilmour J, Gotch F, Patterson S.

Blood. 2001 Oct 15;98(8):2574-6.

11.

HIV-1 co-receptor expression and epithelial immune cells of the cervix in asymptomatic women attending a genitourinary medicine clinic.

McClure CP, Bowman CA, Geary I, Ryan C, Ball JK, Eley A.

HIV Med. 2013 Feb;14(2):108-14. doi: 10.1111/hiv.12002. Epub 2012 Nov 22.

12.

Human plasmacytoid dendritic cells efficiently capture HIV-1 envelope glycoproteins via CD4 for antigen presentation.

Sandgren KJ, Smed-Sörensen A, Forsell MN, Soldemo M, Adams WC, Liang F, Perbeck L, Koup RA, Wyatt RT, Karlsson Hedestam GB, Loré K.

J Immunol. 2013 Jul 1;191(1):60-9. doi: 10.4049/jimmunol.1202489. Epub 2013 May 31.

13.

Induction of CMV-specific T-cell lines using Ag-presenting cells pulsed with CMV protein or peptide.

Einsele H, Rauser G, Grigoleit U, Hebart H, Sinzger C, Riegler S, Jahn G.

Cytotherapy. 2002;4(1):49-54.

PMID:
11953041
14.

Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells.

Smed-Sörensen A, Loré K, Vasudevan J, Louder MK, Andersson J, Mascola JR, Spetz AL, Koup RA.

J Virol. 2005 Jul;79(14):8861-9.

15.

Differential susceptibility of naïve, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission.

Groot F, van Capel TM, Schuitemaker J, Berkhout B, de Jong EC.

Retrovirology. 2006 Aug 17;3:52.

16.

Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses.

Loré K, Adams WC, Havenga MJ, Precopio ML, Holterman L, Goudsmit J, Koup RA.

J Immunol. 2007 Aug 1;179(3):1721-9.

17.

Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection.

Zaunders JJ, Dyer WB, Wang B, Munier ML, Miranda-Saksena M, Newton R, Moore J, Mackay CR, Cooper DA, Saksena NK, Kelleher AD.

Blood. 2004 Mar 15;103(6):2238-47. Epub 2003 Nov 26.

18.

Thymic plasmacytoid dendritic cells are susceptible to productive HIV-1 infection and efficiently transfer R5 HIV-1 to thymocytes in vitro.

Evans VA, Lal L, Akkina R, Solomon A, Wright E, Lewin SR, Cameron PU.

Retrovirology. 2011 Jun 3;8:43. doi: 10.1186/1742-4690-8-43.

19.

Neutralizing antibodies inhibit HIV-1 transfer from primary dendritic cells to autologous CD4 T lymphocytes.

Su B, Xu K, Lederle A, Peressin M, Biedma ME, Laumond G, Schmidt S, Decoville T, Proust A, Lambotin M, Holl V, Moog C.

Blood. 2012 Nov 1;120(18):3708-17. doi: 10.1182/blood-2012-03-418913. Epub 2012 Sep 6.

20.

Supplemental Content

Support Center